California Sues Pharma Giants Over Inflated Insulin Prices
California Attorney General Rob Bonta on Thursday sued the six major companies that dominate the U.S. insulin market, ratcheting up the state’s assault on a profitable industry for artificially jacking up prices and making the indispensable drug less accessible for diabetes patients. The 47-page civil complaint alleges three pharmaceutical companies that control the insulin market — Eli Lilly and...